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Abstract
In Brazil, the presence of plasmid-mediated AmpC (pAmpC)-producing isolates has been sporadi-
cally reported. We evaluated the frequency of pAmpC among 133 Enterobacteriaceae clinical iso-
lates. The blaCMY-2-like gene was detected in a single Klebsiella pneumoniae isolate. In our study, the
pAmpC frequency was very low as previously reported.
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The production of plasmid-mediated AmpC
(pAmpC) enzymes conferring resistance to third-genera-
tion cephalosporins has been increasingly reported among
Escherichia coli, Klebsiella spp., Proteus mirabilis and
Salmonella spp. isolates worldwide (Philippon et al.,
2002). Most acquired ampC genes are derived from chro-
mosomal genes, which are incorporated and mobilized by
plasmids making easier their spread (Pérez-Pérez and
Hanson, 2002). CMY-type enzymes are the most frequent
reported pAmpC -lactamase (Jacoby, 2009). In Brazil, the
presence of pAmpC-producing isolates has been sporadi-
cally reported (Castanheira et al., 2007; Pavez et al., 2008).
FOX-5 and CMY-2 were both detected in E. coli strains
isolated from two distinct Brazilian geographic regions.
The FOX-5 encoding gene was unexpectedly found, during
the DNA sequencing of a 41-kb conjugative plasmid that
harbored a qnrA gene and a class 1 integron with the aadB
and catB3 gene cassettes (Castanheira et al., 2007). On the
other hand, blaCMY-2 was detected in four carbapenem-
resistant E. coli strains isolated successively from a single
patient (Pavez et al., 2008). Despite of these two reports,
studies reporting the pAmpC frequency among Brazilian
isolates are still scarce. Dias and colleagues (Dias et al.,
2008) have studied the prevalence of pAmpC among
Enterobacteriaceae strains isolated from a teaching hospital
in Rio de Janeiro, Brazil. In that study, the production of
pAmpC beta-lactamases were not detected and the multi-
drug resistance phenotype observed in five E. coli isolates
was attributed to the hyperproduction of chromosomal
AmpC (Dias et al., 2008). Since resistance to broad-
spectrum cephalosporins has been commonly observed
among Enterobacteriaceae isolated in our hospital, espe-
cially due to ESBL production, we conducted a study to
evaluate the frequency of pAmpC among
Enterobacteriaceae clinical isolates. We evaluated a total of
133 Enterobacteriaceae (41 E. coli, 05 Klebsiella oxytoca,
65 Klebsiella pneumoniae, 18 P. mirabilis, and 04 Salmo-
nella spp.) isolates consecutively collected from blood-
stream of patients, who were hospitalized at Hospital São
Paulo, São Paulo, Brazil, between January and July 2006.
The antimicrobial susceptibility profile was determined by
agar dilution method and interpreted according to the Clini-
cal Laboratory Standards Institute (CLSI) guidelines
(CLSI, 2009, 2011) recommendations. The following anti-
microbial agents were tested: aztreonam, ceftazidime, cefe-
pime, cefoxitin, ceftriaxone, ciprofloxacin and imipenem.
The ESBL phenotype was detected by double disk approxi-
mation method (Jarlier et al., 1988). The production of
pAmpC among Enterobacteriaceae was phenotypically
screened by modified tridimensional and Hodge tests
(Coudron et al., 2000; Lee et al., 2005). The isolates show-
ing a weak enhanced growth around the test organism
streak at the intersection of the streak and zone of inhibition
were classified as possessing an undetermined result by
modified Hodge test. In the modified tridimensional test,
results were considered undetermined, when the isolates
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showed a weak enhanced growth around the slit containing
the beta-lactamase crude extract. The presence of pAmpC
-lactamases-encoding genes was carried out by multiplex
polymerase chain reaction (PCR) (Pérez-Pérez and
Hanson, 2002). Primers CMY-2F, 5’-ATGATGAAAAA
ATCGTTATGCT-3’ and CMY-2R, 5’-TTATTGCAGCT
TTTCAAGAATGCG-3’ were used to amplify the whole
allele for sequencing of the single isolated detected as
CMY-producer.
The results of this study were summarized in Tables 1
and 2. Twenty-six (20.3%) and three isolates were not sus-
ceptible to cefoxitin and imipenem (MIC90,  0.5 g/mL),
respectively. Among the three imipenem-resistant isolates,
only one isolate was phenotypically detected as an ESBL
producer. This same isolate showed a false-positive result
for pAmpC phenotypical detection by the modified Hodge
test. Among the 133 isolates, 59 (44.4%) were pheno-
typically detected as ESBL producers. The ESBL pheno-
type was more frequently detected among K. pneumoniae
(43 isolates; 72.9%) followed by P. mirabilis (11 isolates;
18.6%), E. coli (4 isolates; 6.8%), and K. oxytoca (1 isolate;
1.7%). The PCR method was considered as the gold stan-
dard method to calculate sensitivity and specificity rates
among isolates evaluated. Both phenotypic methodologies
for detection of pAmpC showed sensitivity of 100%; how-
ever, the specificity rates were different being 96% and
85% for modified tridimensional and Hodge tests, respec-
tively. Discordant results for pAmpC phenotypic detection,
i.e., modified Hodge test results were different from those
displayed by the modified tridimensional test were ob-
served for 16.5% isolates (14 K. pneumoniae, 06 E. coli and
02 P. mirabilis). Among the undetermined (weak positive)
results in the modified tridimensional and Hodge methods,
87.5% and 80% were ESBL producers, respectively. The
presence of blaCMY-2-like gene was observed in a single K.
pneumoniae isolate. Nucleotide sequencing showed that
the blaCMY-2 gene had 99% sequence identity with the
plasmid-encoded blaCMY-2 gene first described in K.
pneumoniae in Greece (Bauernfeind et al., 1996). In the
present study the frequency of ESBL-producing entero-
bacterial isolates (44.4%) was high, while the frequency of
pAmpC-producing isolates was very low. The rates of
ESBL production observed in this study were similar to
other Latin American studies and higher than those re-
ported in other geographic regions (Paterson and Bonomo,
2005). Among Enterobacteriaceae resistance to broad-
spectrum cephalosporins due to pAmpC production is gen-
erally less common than ESBL production in most parts of
the world. However, its frequency might be underestimated
since phenotypic detection of pAmpC enzymes is not easily
achieved. pAmpC-producing isolates might be screened as
ESBL producers according to the former CLSI criteria but
fail in the confirmatory test because pAmpC activity is not
inhibited by clavulanic acid (Jacoby, 2009). Besides, clini-
cal isolates may produce simultaneously both ESBL and
pAmpC (Thomson, 2001). The resistance to cefoxitin
might be used as a marker for AmpC production since
ESBLs do not hydrolyze this agent. However, this pheno-
type may also be due to porin alterations (Thomson, 2001).
Among the isolates that showed positive or undetermined
results for at least one of the pAmpC phenotypic tests,
90.9% and 100% were ESBL-producing K. pneumoniae
and -P. mirabilis, respectively. False detection of carba-
penemase production by the Hodge test has been reported
among ESBL-producing K. pneumoniae isolates that also
had lost OmpK35 and/or OmpK-36 porins (Carvalhaes et
al., 2010). Furthermore, among the E. coli isolates pheno-
typically detected as AmpC producers by the Hodge test,
only a single isolate was an ESBL producer. These findings
might suggest overproduction of chromosomal AmpC,
which is normally produced at low level in this species.
CMY-variant enzymes have been reported worldwide, with
the CMY-2 variant being the most prevalent and widely
distributed so far (Philippon et al., 2002). Given the ability
of pAmpC-producing organisms to hydrolyze many -lac-
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Table 1 - Antimicrobial susceptibility among K. pneumoniae, E. coli and P. mirabilis isolates.
Species/(no. tested) K. pneumoniae (65) E. coli (41) P. mirabilis (18)
Antimicrobials tested MIC(g/mL)a S% R% MIC(g/mL)a S% R% MIC(g/mL)a S% R%
MIC50
b MIC90
b MIC50
b MIC90
b MIC50
b MIC90
b
Aztreonam 64 256 32.3 67.7
 1 16 78.0 12.1  1 8 88.9 5.6
Cefoxitin 8 32 64.6 24.6 4 8 95.1 0.0 2 8 94.4 5.6
Ceftriaxone 256 > 512 29.2 70.8
 1 32 78.0 14.5 32 512 33.3 66.7
Ceftazidime 32 64 32.3 67.7
 1 2 95.1 0.0  1 8 88.9 0.0
Cefepime 32 64 36.9 60.0
 1 4 92.7 4.8 32 128 38.9 55.6
Imipenem
 0.5  0.5 95.4 3.0  0.5  0.5 100.0 0.0  0.5 1 100.0 0.0
Ciprofloxacin 16 > 32 33.8 66.2
 0.12 32 82.9 17.1 4 16 27.8 55.6
a. MIC, minimal inhibitory concentration determined by agar dilution CLSI (2009).
b. MIC50 and MIC90, minimal inhibitory concentration that inhibited 50% and 90% of bacterial isolates tested, respectively.
tam antibiotics, the carbapenems are the therapeutic of
choice for treating infections caused by such organisms.
However, the clinical usefulness of those important antimi-
crobials has been jeopardized by the emergence of carbape-
nem-resistant K. pneumoniae due to pAmpC and/or ESBL
producer coupled with porin loss (Philippon et al., 2002)
and more recently by the emergence and spread of carbape-
nemase producing isolates. Although reported with in-
creasing frequency in other geographic regions, our results
agreed with previous reports and pointed out that pAmpC
were not frequent in our institution (Dias et al., 2008).
ESBL production is still the main mechanism of resistance
to broad-spectrum cephalosporin among clinical isolates.
Despite of the low pAmpC frequency in our hospital (data
not shown), continuous surveillance is important for early
detection of this mechanism of resistance and prevention of
its spread since it was already detected in our environment.
Moreover to reach this aim, the development of accurate
phenotypic tests is urgently needed.
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